Finance

Beta
Lists
EII:FRA
Eisai Co Ltd
€20.77
-2.07%
(-0.44) 1D
Jun 19, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for EII...
Open
€20.77
High
€20.77
Low
€20.77
Mkt. cap
1.14T
Avg. vol.
20.00
Volume
0.00
52-wk high
€31.41
52-wk low
€19.70
No. of employees
11K
Open
€20.77
High
€20.77
Low
€20.77
Mkt. cap
1.14T
Avg. vol.
20.00
Volume
0.00
52-wk high
€31.41
52-wk low
€19.70
No. of employees
11K
News stories
From sources across the web
Profile
Eisai Co., Ltd. is a Japanese pharmaceutical company headquartered in Tokyo, Japan. It has some 10,000 employees, among them about 1,500 in research. Eisai is listed on the Tokyo Stock Exchange and is a member of the Topix 100 and Nikkei 225 stock indices. Wikipedia
About Eisai Co Ltd
CEOHaruo Naito | Haruo Naito
Employees10.5K
FoundedDec 6, 1941
HeadquartersBunkyo City, Tokyo, Japan
SectorPharmaceutical industry
Websiteeisai.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
202.65B
197.36B
219.94B
205.43B
Cost of goods sold
42.60B
45.52B
51.08B
52.02B
Cost of revenue
42.60B
45.52B
51.08B
52.02B
Research and development expenses
38.79B
36.74B
39.20B
43.94B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
99.97B
104.06B
111.72B
108.23B
Operating expense
139.11B
138.36B
148.82B
163.92B
Total operating expenses
181.71B
183.88B
199.90B
215.94B
Operating income
20.94B
13.48B
20.03B
-10.51B
Other non operating income
1.00M
1.00M
-1.00M
-66.00M
EBT including unusual items
22.40B
14.53B
22.00B
-7.94B
EBT excluding unusual items
22.60B
14.34B
22.00B
-10.55B
Income tax expense
7.07B
4.00B
4.16B
-4.75B
Effective tax rate
31.55%
27.51%
18.90%
59.77%
Other operating expenses
353.00M
-2.44B
-2.10B
250.00M
Net income
14.47B
10.16B
17.18B
-3.25B
Net profit margin
7.14%
5.15%
7.81%
-1.58%
Earnings per share
-
-
-
-
Interest and investment income
2.58B
2.30B
3.40B
462.00M
Interest expense
-916.00M
-1.44B
-1.43B
-439.00M
Net interest expenses
1.66B
856.00M
1.97B
23.00M
Depreciation and amortization charges
-
-
-
11.51B
EBITDA
30.64B
23.29B
30.10B
-530.00M
Gain or loss from assets sale
-
1.31B
-
1.40B
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer